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Abstract
Background: Diabetic nephropathy (DN) is a complex and chronic metabolic disease that evolves into a progressive fibrosing
renal disorder. Effective transcriptomic profiling of slowly evolving disease processes such as DN can be problematic. The
changes that occur are often subtle and can escape detection by conventional oligonucleotide DNA array analyses.
Methodology/Principal Findings: We examined microdissected human renal tissue with or without DN using Affymetrix
oligonucleotide microarrays (HG-U133A) by standard Robust Multi-array Analysis (RMA). Subsequent gene ontology analysis
by Database for Annotation, Visualization and Integrated Discovery (DAVID) showed limited detection of biological
processes previously identified as central mechanisms in the development of DN (e.g. inflammation and angiogenesis). This
apparent lack of sensitivity may be associated with the gene-oriented averaging of oligonucleotide probe signals, as this
includes signals from cross-hybridizing probes and gene annotation that is based on out of date genomic data. We then
examined the same CEL file data using a different methodology to determine how well it could correlate transcriptomic
data with observed biology. ChipInspector (CI) is based on single probe analysis and de novo gene annotation that bypasses
probe set definitions. Both methods, RMA and CI, used at default settings yielded comparable numbers of differentially
regulated genes. However, when verified by RT-PCR, the single probe based analysis demonstrated reduced background
noise with enhanced sensitivity and fewer false positives.
Conclusions/Significance: Using a single probe based analysis approach with de novo gene annotation allowed an
improved representation of the biological processes linked to the development and progression of DN. The improved
analysis was exemplified by the detection of Wnt signaling pathway activation in DN, a process not previously reported to
be involved in this disease.
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Introduction
DN is a complex metabolic disease that evolves into a
progressive fibrosing kidney disease. It represents the leading
cause of end-stage renal failure in the industrialized world. A series
of pathogenic mechanisms have been shown to contribute to this
chronic progressive disease including: hyperglycemia with ad-
vanced glycosylation end products, hemodynamic and vascular
alterations with albuminuria, and the intrarenal production of
growth factors and matrix components [1]. In recent years it also
became evident that inflammatory mechanisms contribute signif-
icantly to the development and progression of DN. These include
the infiltration of renal compartments by lymphocytes and
monocytes/macrophages as well as local production of cytokines
and chemokines in the kidney (recently summarized in [2,3]).
Specific inflammatory and angiogenic molecular pathways have
been recently linked to progressive DN by the analysis of human
renal gene expression profiles [4,5].
While morphometric analysis of renal biopsy samples can
demonstrate an inflammatory infiltrate in most advanced DN
samples, it has been difficult to reliably characterize inflammatory
features at the transcriptomic level suggesting insufficient resolu-
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tion or sensitivity of oligonucleotide microarrays or of the data
analysis.
This uncertainty in reliable detection of gene expression is thought
to be associated with several issues connected to oligonulceotide
microarrays such as Affymetrix DNA chips. First, the current
annotation associated with a considerable number of probe sets may
not be in line with current knowledge of the genome [6,7]. Second,
the current approach of averaging oligonucleotide signals in a gene-
oriented way impairs the resolution of splice isoforms or alternative
transcripts. Signals from cross-hybridizing probes are averaged into
the probe set calculation leading to increased ‘‘noise’’ in the analysis.
Researchers have attempted to address these problems by re-
defining probe sets accordingly [6]. However, the pace of continued
discovery of additional alternative mRNA transcripts and the
constant refinement of gene annotation has demonstrated that such
improvements were temporary, and can propagate the basic
problems of probe set annotation. These issues are directly relevant
for accurate analysis of array experiments independent of any
particular statistical methods used.
We choose to apply two existing program packages in order to
elucidate how well each of these methods correlates the same
transcriptomic data with the observed biology. One, Robust
Multi-array Analysis (RMA) is based on Affymetrix probe sets,
while the other, ChipInspector (CI), is based on single probe
analysis, bypassing probe set definitions entirely. In theory, the CI
approach should provide a reduced level of experimental
‘‘background noise’’ with potentially enhanced sensitivity.
To test this hypothesis, samples taken from human renal tissue
with or without DN were compared and contrasted using
conventional and single probe analysis. A common data set of
CEL files (Affymetrix HG-U133A) was analyzed using standard
techniques (RMA) followed by significance analysis of microarrays
(SAM) [8]. In parallel single probe analysis was performed using
default settings (CI also using SAM) and yielded comparable
numbers of regulated genes. However, gene ontology analysis by
Database for Annotation, Visualization and Integrated Discovery
(DAVID) [9] of both data sets showed a clearly improved
representation of biological processes linked to the development
and progression of DN for the single probe-based approach. The
single probe methodology allowed the unique detection of Wnt-
pathway activation in DN.
Results
Comparison of prior microarray studies with biological
phenomena indicates the need for increased sensitivity
in array analysis
Inflammatory processes may underlie important events in the
pathogenesis of DN [10]. We previously demonstrated activation
of the inflammatory transcriptional regulators nuclear factor-
kappa B (NFkB) and interferon regulatory factor (IRF) linked to
the progression of DN [4]. This observation prompted us to look
more closely for evidence of inflammatory events in DN. Biopsy
samples from patients presenting with advanced DN were
examined by immunohistochemistry for specific inflammatory cell
types. Staining for T cells (markers CD3, CD8), B cells (CD45RA)
and monocytes/macrophages (CD68) showed a prominent
infiltration in the renal tubulo-interstitium of patients with
advanced DN (Fig. 1 and supplemental data, Table S1).
Although histological characterization clearly demonstrated in-
flammatory processes at work in samples of advanced DN, RMA
based array and gene ontology (GO) analysis could identify only
limited regulation of GO categories associated with inflammation
suggesting a more sensitive approach was needed [4].
Parallel array analysis by probe set- and single probe-
based approaches
Affymetrix DNA array data were analyzed in parallel using
single probe-based analysis (CI) and conventional probe set-based
algorithms (RMA). Expression profiles (CEL files) from microdis-
sected tubulo-interstitial regions from patients with advanced DN
(n= 6) and kidneys without functional alterations from living
donors (LD, n= 3) were used in the subsequent analysis (see Fig. 2
for schematic overview).
The microarray HG-U133A used in this study contains 195,294
single oligonucleotide probes with different sequences (control
mismatch probes not included). These probes are used to generate
22,283 probe sets annotated by the manufacturer to 12,742 genes
(Affymetrix, version 22).
The probe set-based analysis using RMA normalization
identified 10,698 probe sets (48%) expressed above background.
Figure 1. Tubulo-interstitial CD68+ cell infiltrate in DN. (a) In DN
a prominent infiltration of CD68+ cells (monocytes/macrophages,
stained in red) is observed in the tubulo-interstitium. A glomerulus
showing nodular glomerulosclerosis (Kimmelstiel-Wilson), a classical
histological sign for DN, has no prominent infiltrate. In control tissue (b)
only few cells are CD68+. Together with the staining for CD3 and CD8
(shown in Table S1) this demonstrates the significant inflammatory
reaction in DN.
doi:10.1371/journal.pone.0002937.g001
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Significance analysis using SAM detected differential regulation of
2,350 unique genes, corresponding to 3,078 probe sets (q-
value,5%, multiple comparison analysis of DN and controls as
determined in previous studies, see methods).
After elimination of probes that could cross-hybridize to other
transcripts, CI using the identical CEL files identified 39,933
significantly regulated individual probes using the default settings
(see methods for details). With default settings of a minimum of 3
probes matching to a de novo annotated transcript, 6,533 transcripts
were found to be significantly regulated, corresponding to 2,626
genes.
The initial analysis summarized in Fig. 2 identified 1,466 genes
found in common by both approaches. CI uniquely identified
1,160 genes and 884 genes were unique to the RMA analysis.
While this shows a solid common core of regulated genes, gene lists
per se are not suitable for evaluation of the biologically meaningful
differences between the resulting lists. As our goal was to identify
biological processes involved in DN, we mapped the genes from
Figure 2. Schematic overview. The strategy of analysis and verification is depicted. Links to the data for each step are provided on the right. All
genes where expression changes were predicted and verified by RT-PCR bear a green check mark; if not confirmed by RT-PCR, a red cross-mark is
shown. In Step 5 only genes are shown that were both found significantly upregulated (white =both approaches, black CI only) and known Wnt
pathway target genes.
doi:10.1371/journal.pone.0002937.g002
Diabetic Nephropathy Analysis
PLoS ONE | www.plosone.org 3 August 2008 | Volume 3 | Issue 8 | e2937
each approach onto GO. A relative ranking of the association of
the various GO-categories with respect to the gene lists was carried
out employing DAVID. The DAVID tool was developed for GO-
ranking, and is independent of methodological differences between
the microarray analyses tools used in this study. DAVID assigns a
p-value to each biological process associated with the gene lists. As
both methods (RMA, CI) yielded comparable numbers of genes
under the conditions used, results from the DAVID analysis could
be used to directly compare the methods.
Single probe-based analysis identifies more specific
functional categories than the probe set-based analysis
DAVID analysis of all regulated genes and transcripts found by
the two analysis techniques yielded 174 common GO-categories
(supplemental data, Table S2; cut-off p-value 0.05) again
demonstrating the significant common core of both data sets.
The CI-based associations showed overall lower p-values in these
common 174 GO-categories (lower p-value in 137 of 174
categories). For the sake of comparison only significant (p,0.05)
categories were used in subsequent analyses. DAVID found an
additional 104 significant GO-categories uniquely associated with
the CI-derived gene list, while the RMA-derived list matched
uniquely to 63 additional significant GO-categories (supplemen-
tal data, Table S3).
As the study was initiated by a search for inflammatory gene
signatures involved in DN, we compared functional categories
covering inflammatory mechanisms. Both methods identified seven
common inflammation-associated GO-categories (GO:0019883,
GO:0019885, GO:0006956, GO:0006958, GO:0002455,
GO:0006959, GO:0045087; Table S2). Importantly, CI analysis
listed 13 additional GO-categories not found by the RMA analysis
(GO:0019730, 0006952, 0045321, 0006955, 0006954, 0046649,
0050778, 0051251, 0050870, 0051249, 0050863, 0009605, and
0042110; see Table S3). No inflammation-associated GO-classifi-
cation was found uniquely by the probe set-based approach.
In a recent report we described the regulation of angiogenesis-
associated genes in DN, including the down-regulation of the
vascular endothelial growth factor A (VEGF-A) [5]. Comparing
angiogenesis-associated GO-categories showed that the gene list
generated by CI included significant counts for ‘‘angiogenesis’’
(GO:0001525), ‘‘blood vessel development’’ (GO:0001568), ‘‘blood vessel
morphogenesis’’ (GO:0048514), and ‘‘vasculature development’’
(GO:0001944). In contrast, no significant angiogenesis-associated
categories were identified by RMA analysis (Table S3).
Functional categories uniquely found by each approach
and confirmatory studies
Each of the approaches uniquely identified GO-categories,
although individual genes belonging to these categories were
identified by each method. To analyze the results in more detail,
we then selected genes from potentially relevant functional
categories not been previously reported in DN. In this regard,
neurogenesis identified by RMA-based analysis, and the Wnt
signaling pathway found by the CI approach were chosen for
further analysis.
‘‘Neurogenesis’’ was represented by six GO-categories in the
RMA-based gene lists (GO:0048813, GO:0048812, GO:0022008,
GO:0048666, GO:0030182, and GO:0048667) but absent as GO
category in the single probe analysis. The unique lists contained 1,
6, 9, 7, 8, and 6 genes for RMA in above GO categories and 0, 5,
5, 5, 5, and 5 genes for CI, respectively (see Table S3 and
supplemental data, Table S4). RT-PCR analysis of the
original cDNA used for hybridization was used to verify expression
of the two genes showing the highest fold-change in the lists of
neurogenesis-associated genes uniquely found by probe set- and
single probe-based approaches. SOCS2 and SPON2 were selected
from the RMA-list of genes, for the CI-generated list the genes
APOE and NRCAM were tested (Table S3 and supplemental
data, Table S5a). Expression was confirmed for transcripts of
APOE (predicted by CI), NRCAM (CI), and SPON2 (RMA),
while SOCS2 (RMA) could not be verified by RT-PCR (Fig. 3
and Table S5a).
The Wnt signaling pathway (GO:0016055) was identified only in
DAVID analysis of CI-derived gene list, but significantly regulated
genes from the Wnt pathway were identified by both approaches.
CI matched 14 genes uniquely while RMA identified 5 genes
uniquely. Again the genes showing the highest fold change in each
approach-specific gene list were further analyzed by RT-PCR
(TCF7L2 and LEF1 for RMA and TCF7 and DACT1 for CI)
(Table S3 and Table S5a). The mRNA expression was
confirmed for the TCF7 (CI) and LEF1 (RMA) transcripts. The
predictions of DACT1 (CI) and TCF7L2 (RMA) could not be
verified by RT-PCR (Fig. 3).
The number of probes with ambiguous matches is listed in
supplemental Table S5b for each of the selected probe set.
Ambiguous matches were found in TCF7 and TCF7L2, the later,
a gene recently linked to the development of diabetes (but not DN)
[11,12]. Importantly, the probe set 216511_s_at for TCF7L2 was
found to map downstream of all three transcripts annotated for
TCF7L2. Two additional probe sets for TCF7L2 mapped to exons
and were not listed as regulated in DN by either approach (see
Table S5a and b).
Wnt signaling in diabetic nephropathy
The potential relevance of Wnt signaling in advanced DN was
investigated in more detail. Mapping the respective genes found by
each approach onto the canonical Wnt pathway was performed
(KEGG [13] and Biocarta databases (BioCarta Pathways; http://
www.biocarta.com/genes/index.asp)). As shown in Fig. 4, and in
line with previous findings, the CI-analysis identified a much larger
fraction of the pathway as regulated than did the RMA analysis (23
versus 15 out of 27 genes, see Table S3 and Table S4). The
potential downstream effects of this pathway on known Wnt target
genes were then examined. Of the knownWnt target genes regulated
on the microarray 15 of 15 were identified by CI while RMA
identified 10 (Fig. 4 and Table S4). Matrix metalloproteinase 7
(MMP7) [14] showed the highest fold-change in Wnt-associated
genes and was confirmed by RT-PCR on the cDNA used for the
array analysis (DN 40.09623.88, LD: 1.061.73 (p,0.05)) as well as
on an independent cohort of patients with DN (DN: 6.4566.62; LD:
1.0060.79 (p,0.05)) (Fig. 5a). The induction of MMP7 protein was
verified by immunohistochemistry: MMP7 protein expression was
strongly increased in the tubulo-interstitial compartment of patients
with DN (Fig. 2 and Fig. 5b,c)
Discussion
DN develops gradually in response to systemic metabolic
changes and the cellular responses to these effects. The molecular
mechanisms that underlie progression of the disease to end stage
renal failure are not well defined thus limiting access to potential
therapeutic targets.
In contrast to the immune reaction in response to acute infection
or inflammation, the immune processes in chronic diseases such as
DN can be ‘‘smoldering’’ processes that are hard to detect. The
pathophysiologic effects elicited by such an immune cell infiltrate
lead to the accumulation of subtle damage over a long period of time
Diabetic Nephropathy Analysis
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[10]. Understanding the small changes in the biological networks
that regulate these processes is central to characterizing the
underlying pathogenetic events. Elucidation of the regulatory
networks driving the tissue damage could thus improve the diagnosis
in what can now be seen a heterogeneous disease and may help to
identify potential targets for therapeutic intervention.
Microarrays are widely applied for the characterization of
transcriptomic changes in diseased tissues. However, in previous
array analyses the approach has failed to detect some of the subtle
changes that occur in patient samples associated with the
development of chronic disease [4,5]. Lowering thresholds for
the detection of significantly regulated genes using standard
analysis approaches results in an increase in ‘‘background noise’’
in the experiment and increasingly unreliable results [15].
Previous reports have outlined the potential advantages of using
a single probe-based approach for gene annotation and expression
analysis [16]. Therefore, we directly compared a single probe-
based method (CI) with a common probe set-based method
(RMA). The overall picture that emerged from the CI analysis was
more inline with the pathologic observations. After confirmatory
RT-PCR studies the analysis of the probe signals suggested that
differences in single probe versus probe set calculation were a
major reason for the differences observed between the two analysis
methods (RMA, CI). Fig. 6 demonstrates the effect that basing
calculations on single probes versus probe sets can have in the
analysis. The difference between the signals of the individual
probes mapped to NRCAM shows why this gene escaped
detection based on an average value of all these probes by
RMA. DACT1 predicted to be regulated by CI narrowly missed
statistical significance at the confirmatory studies (p = 0.07)
probably in part due to different statistical methods applied to
array and RT-PCR results. While the results appeared to favor the
single-probe approach a few genes were missed by CI due to
insufficient coverage by unique mapped probes (LEF1) or because
the probe annotations were not yet included in the database at the
time of analysis (SPON2, see Table S5b).
The comparative analysis detailed here was based on probe
annotation and aspects of the relevant underlying biology. The
different statistics employed inside the methods will additionally
influence the result. However, as the goal of this study was to
improve the links between transcriptomic analyses and biological/
clinical observations, it is irrelevant to what extent probe annotation
and/or algorithmic differences are contributing to the performance
of the two program packages. Overall association with biological
processes was found to be improved for the single probe-based
method as judged by the number of GO-categories and genes
associated with relevant processes (inflammation and angiogenesis).
Moreover, signaling pathways were easier to identify and superpo-
sition of the significantly regulated genes yielded overall a more
complete picture provided by the single probe-based analysis.
In the course of the study the Wnt pathway was identified to be
associated with DN. This important biological pathway has not
been studied in detail in DN. The Wnt signaling pathway is known
to play a role in renal development and cystogenesis [17]. The
most highly regulated Wnt target gene identified in the analysis
was MMP7. Diverse roles for matrix metalloproteinases have been
postulated in various renal pathophysiologies [18]. A reduced
expression of MMP7 has been recently described in rodent models
of DN [19] but no human data on MMP7 expression in DN has
been reported. Contrary to what has been reported in the rodent
models, MMP7 was shown to be induced mainly in tubular
epithelial cells in human DN. Discrepancies between the findings
in rodent models for DN and human disease have been previously
reported (e.g. [5,20]). While the up-regulation of a matrix
Figure 3. Validation of the array expression pattern by real-
time RT-PCR. The expression of selected transcripts predicted by CI or
RMA, respectively, was tested by real-time RT-PCR. The same cDNA
hybridized on the array was used. Expression is shown for controls
(living donors (LD), n = 3, triangles) and DN (n= 6, full circles). In the
upper left corner gene symbols and predictions by each method are
indicated (red arrow: induced, green arrow: reduced, black arrow: not
regulated, compared to controls). Blue check indicates confirmation of
the respective prediction. The results in detail: Genes associated with
neurogenesis: APOE (predicted by CI) LD 1.0060.08, DN 0.4560.33
(p,0.05); SOCS2 (predicted by RMA) LD 1.0060.58, DN 1.4260.50
(n.s.); NRCAM (CI) LD 1.0060.57, DN 4.6163.56 (p,0.05); SPON2
(RMA): LD 1.0060.92, DN 25.47613.98 (p,0.05). Genes associated with
Wnt signaling: TCF7 (predicted by CI): LD 1.0060.41, DN 5.9862.49
(p,0.05); TCFL7 (predicted by RMA): LD 1.0060.36, DN 1.7260.55
(n.s.); DACT1 (CI): 1.0060.50, DN 3.4761.894 (n.s.); LEF1 (RMA): LD
1.0060.27, DN 5.3762.49 (p,0.05).
doi:10.1371/journal.pone.0002937.g003
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degradating protease in a setting of chronic fibrosis seems
counterintuitive, the MMP family plays diverse roles in regulating
tissue remodeling [21].
The RMA based approach uniquely identified neurogenesis
processes that may also be relevant in DN. However, in contrast to
the Wnt signaling pathway, neurogenesis was not represented by a
Figure 4. Mapping of respective genes found by CI or RMA onto the canonical Wnt-pathway. A scheme of the Wnt-pathway is depicted.
Black arrows indicate activation and red lines inhibition. Genes found only by CI are annotated with CI with a blue background (n = 13, 2 genes
[NRCAM, TCF7] confirmed by real-time RT-PCR, 1 gene failed [DACT1]), while genes only found by the RMA approach have a grey background with a
black frame and are marked with RMA (n= 4, only 1 gene [LEF1] confirmed by real-time RT-PCR, 1 gene [TCF7L2] failed). Genes found by both
approaches are annotated with CI and RMA and on a white background (n = 12, 1 gene confirmed by RT-PCR [MMP7]). A red triangle indicates up-
regulation of the respective gene. Genes which were not found by any array analysis but are important for the comprehension of the basic pathway
have a grey font. Comparison of known Wnt-target genes resulted in 15 genes specifically regulated in the microarray analysis (below the horizontal
line). The respective genes found only by CI (n = 5) have a blue background (1 gene [NRCAM] confirmed by real-time RT-PCR), while the genes (n = 10)
found by both approaches have a white background. VEGF was the only gene found to be down-regulated. There were no Wnt target genes only
found by RMA. Gene symbols are according to HUGO, synonyms are shown in brackets.
doi:10.1371/journal.pone.0002937.g004
Diabetic Nephropathy Analysis
PLoS ONE | www.plosone.org 6 August 2008 | Volume 3 | Issue 8 | e2937
single GO-category but was rather represented by six different
processes. All but one of them also showed a robust, although not
significant representation in the list of unique genes from CI
(Table S3 and Table S4; respective SPON2 see Table S5b).
The potential finding of neurogenesis-associated processes in DN
will need further verification and additional experiments in future.
A significant difference (p,0.05) in confirmatory RT-PCR
experiments using the same cDNA as for the microarray
hybridization served as a stringent paramenter for microarray
analysis evaluation. However, as group sizes were limited, gene
regulation in DN of some genes defined as ‘‘false positives’’ can not
be excluded.
In summary, the single probe based analysis of oligonucleotide
based arrays demonstrated clear advantages over the common
probe set-based approach used in this study, most notably resulting
in improved sensitivity and specificity of the biological findings
(DAVID analysis). This was highlighted by the unique detection of
a number of categories directly linked to clinical observations
(inflammation and angiogenesis). In addition, the highlighted
involvement of the Wnt pathway was in line with a larger body of
data from the same microarray (Wnt target genes, Fig. 2 and 4).
Materials and Methods
Kidney biopsies, micordissection, RNA isolation and
target preparation
Human renal biopsies from controls and patients with DN were
collected from the European Renal cDNA Bank - Kro¨ner-
Fresenius Biopsy Bank (ERCB-KFB), a multi-center study on renal
gene expression in human nephropathies. Diagnostic renal
biopsies were obtained from patients after informed consent and
with approval of the local ethics committees. Microdissected
samples taken from the tubulo-interstitial compartment were
processed as described [22]. For oligonucleotide array based gene
expression profiling of DN a total of 9 kidney biopsies from
individual patients were included: Biopsies from patients with
advanced DN (n= 6) were analyzed and compared with pre-
transplantation kidney biopsies from living donors as control renal
tissue (LD, n= 3). For confirmation of MMP7 induction, predicted
by both array analysis approaches, an additional independent
cohort from the ERCB-KFB was analyzed (DN, n= 16; controls,
n = 9). The biopsies were stratified by reference pathologists
according to their histological diagnosis.
Following renal biopsy, the tissue was transferred to RNase
inhibitor and microdissected into glomerular and tubular frag-
ments. Total RNA was isolated from microdissected tubulointer-
stitial tissue (for details see [22]).
300–800 ng of total RNA was reverse-transcribed (RT) and
linearly amplified according to a protocol previously reported [4].
The fragmentation, hybridization, staining and imaging were
performed according the Affymetrix Expression Analysis Techni-
cal Manual.
For microarray analysis Robust Multichip Analysis (RMA) was
performed. Subsequently we analyzed the expression arrays with
Significance Analysis of Microarrays (SAM) [8]. For more details
and for gene expression data of respective probe sets see http://
diabetes.diabetesjournals.org/cgi/content/full/55/11/
2993.
Microarray Data Analysis
To compare the respective analysis approaches both methods
used the same original CEL files resulting from the Affymetrix
Chip reader. Both program packages were used with either default
or previously tested parameters.
Figure 5. MMP7 mRNA expression is increased in DN. (a) MMP7
mRNA was quantified by RT-PCR on an independent cohort and
showed an induction in DN (DN (n = 16): 6.4566.62; LD (n = 9):
1.0060.79 (p,0.05)). MMP7 protein (marked in red) is also induced in
DN as shown by immunohistochemistry. (b) Control kidneys show
limited expression of MMP7 protein in tubular epithelial cells. (c) In DN,
MMP7 is markedly upregulated in tubular epithelial cells and in the
interstitial compartment.
doi:10.1371/journal.pone.0002937.g005
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I. Probeset-based analysis: Robust Multichip Average
(RMA). RMA (RMAexpress version 0.3) consists of three steps:
background adjustment, quantile normalization, and summariza-
tion [23]. RMA utilizes the Affymetrix provided probe set
annotation to identify genes directly from the CEL files. The
following settings were taken from previous studies [4,5]: a
background filter cut-off was defined to lower the count of false
positive calls using the highest signal value obtained from non-
human Affymetrix control oligonucleotides multiplied by a factor
of 1.2, corresponding in the current data set to a log based 2 value
of 5.8. Following normalized RMA, SAM analysis software (TIGR
MeV Version 4.01, http://www-stat.stanford.edu/˜tibs/SAM/)
was applied using a q-value,5% to identify genes that were
differently regulated between the analyzed groups.
II. Single probe-based analysis: ChipInspector
(CI). ChipInspector (version 1.3; Genomatix Software GmbH,
Munich) is a novel single probe-based analysis tool for microarray
data that consists of four steps: single probe-transcript annotation,
total intensity normalization, SAM analysis (adapted to single
probe handling) and transcript identification based on significantly
changed probes. All probes on the array are individually matched
against the appropriate genome and all known transcripts thereof
available at the time of analysis. Only probes that match uniquely
to the genome and to at least one transcript (or overlapping
transcripts) are retained for further analysis. The input data for the
SAM analysis in this case were single probe values and the
resulting probes showing significantly changed signals are then
used to identify the corresponding transcripts (which may be more
than one per gene). Fold changes are not used and the expression
ratios shown in the result table are calculated from the average
expression levels of all significant probes of each individual
transcript. Gene identifiers are then attached to each transcript.
SAM creates artificial background data by randomly permuting
the array results. Each probe has a score on the basis of its fold
change relative to the standard deviation of repeated measure-
ments for this probe. Probes with scores higher than a certain
threshold are deemed significant. This threshold is the Delta value.
The permutations of the data set are then used to estimate the
percentage of probes identified by chance at the identical Delta.
Thus, a relation of significant probes to falsely discovered probes
can be given for each Delta threshold. This relation is the False
Discovery Rate (FDR), a stringency indicator. Analysis was carried
out using all default settings as recommended by the software
provider, except for the expected FDR, which was set to maximal
detection of regulated transcripts with lowest amount of falsely
called features (FDR 0%).
Ranking of RMA and CI results by GeneOntologyChart
The GOChart in DAVID (version 2007; [9]) was used to establish
the distribution of differentially regulated genes attributed to
functional biologic categories for both resulting gene lists. The
controlled hierarchical vocabulary of the Gene Ontology Consor-
tium provides a structured language that can be applied to the
functions of genes and proteins in all organisms [24]. The biological
theme determination of gene lists in DAVID are based on the
Expression Analysis Systematic Explorer (EASE), a variant of one-
tailed Fisher exact probability [25]. At the time of analysis multiple
comparison correction was not implemented in DAVID because it
has been considered to be too conservative and might hurt biology
(communication of DAVID, 24 March 2007). For DAVID analyses
a p-value of 0.05 was used as standard cut-off level.
RT-PCR analysis used for validation
Reverse transcription and real-time RT-PCR was performed as
reported earlier [22]. Pre-developed TaqMan reagents were used for
human APOE, DACT1, LEF1, NRCAM, SOCS2, SPON2, and
18S rRNA (Applied Biosystems). For TCF7 and TCF7L2 the
following oligonucleotide primers (300 nmol/L) and probe
(100 nmol/L) were used: human TCF7, sense primer 59-TCAGG-
GAAGCAGGAGCTG-39, antisense primer 59-TTCTTGATG-
GTTGGCTTCTTG-39; fluorescence labeled probe (FAM) 59-
ACCGCAACCTGAAGACACAAGCAGA-39, human TCF7L2
Figure 6. Graphical overview of the gene locus of NRCAM. A schematic view of the NRCAM gene structure (NM_005010) is shown consisting
of 28 exons (black rectangles). Probes of the respective probe sets are indicated as blue or red bars. Red bars indicate probes with significantly higher
signal intensity in DN samples compared to controls; blue bars represent probes indicating no induction or repression. The height of each bar
indicates the fold-change for each single probe.
doi:10.1371/journal.pone.0002937.g006
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sense primer 59-GGATTCAGACACCCCTACCC-39, antisense
primer 59-CGTGTGTAGCGTATGATGTGG-39; fluorescence
labeled probe (FAM) 59-CAATGCTTCCATGTCCAGGTTC-
CCT-39. The expression of candidate genes was normalized to the
reference gene 18SrRNA showing robust expression in human
tubulo-interstitial tissue samples [26]. The mRNA expression was
analyzed by standard curve quantification.
Immunohistochemistry
Immunohistochemistry for T cells, B cells and monocyte/
macrophages was performed essentially as described [27]. The
MMP7 monoclonal antibody (Thermo Scientific, Fremont, CA,
#MS-813-R7) was used according to the manufactures directions
at a dilution of 1:20.
Statistics used for RT-PCR result evaluation
Data are given as mean6SD. Statistical analyses were
performed using SPSS 16.01 (SPSS Inc., Chicago, IL). Signif-
icance in immunohistochemical staining was evaluated using
Kruskal-Wallis and Mann-Whitney U tests. The non-parametric
two-sample test of Kolmogorov-Smirnov as well as the Moses-test
were applied to the real-time RT-PCR analyses of eight selected
candidate genes. A p-value,0.05 indicates a statistically significant
difference.
Supporting Information
Table S1 Quantification of immunohistochemical staining for
cell infiltrate. Renal biopsy tissue was stained for the T-cell
markers CD3, CD8, B-cells (CD45RA) and monocytes/macro-
phages (CD68). In DN (n= 7) CD3+ cells, CD8+ cells, overall T-
cells and B-cells and CD68+ cells were more frequently observed
than in controls (n = 4) (*: p,0.05).
Found at: doi:10.1371/journal.pone.0002937.s001 (0.04 MB
DOC)
Table S2 Prominent biological aspects found by DAVID
analysis in both ChipInspector and RMA output lists. Shown
are the 174 biological aspects found by both approaches. Gene
ontology categories found only by one of both approaches are
listed in Table S3.
Found at: doi:10.1371/journal.pone.0002937.s002 (0.44 MB
DOC)
Table S3 DAVID analysis of all regulated genes and transcripts
found by the two independent array analysis techniques. Shown
are the prominent biological aspects found by CI only (‘‘Class 1’’)
or RMA only (‘‘Class 2’’). In total 174 common GO-categories
were found (see, Table S2), additional 104 GO-categories were
uniquely associated with the CI-derived gene list, while 63
additional GO-categories were found by RMA only.
Found at: doi:10.1371/journal.pone.0002937.s003 (0.35 MB
DOC)
Table S4 Gene list of Wnt receptor signaling pathway,
neurogenesis, and Wnt target genes. Genes of the selected GO
categories are shown with their respective regulation indicated by
either analysis method. Bold are the gene symbols of genes with
the highest fold changes, which were selected for confirmatory
studies. In addition, Wnt target genes are listed. Only fold changes
indicated as significant by the respective method are shown.
Found at: doi:10.1371/journal.pone.0002937.s004 (0.34 MB
DOC)
Table S5 Probe set information and analysis results for the genes
selected for confirmatory studies. A) Results of the analyses
performed with CI and RMA are shown. Fold change and
significance are given for all transcripts (for CI) or probe sets (for
RMA) indicated by one of both methods to be significantly
regulated. * indicates significance, n.s. = not significant, BC= ex-
pression below cut-off (see method section). SPON2 was missed by
the initial version of CI (see above). B) Shown are the number of
probes in a probe set, number of probes with a perfect and with a
unique match, and the number of probes mapping to an exon.
The information has been extracted from Eldorado (Genomatix,
Germany). Accession numbers for known transcripts and probe set
identification numbers are listed. SPON2 was not annotated in
Eldorado at the time of analysis. The latest version gives results
indicated as ‘‘corrected’’.
Found at: doi:10.1371/journal.pone.0002937.s005 (0.15 MB
DOC)
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